# Jengu Therapeutics, Inc. — Form D

Jengu Therapeutics, Inc. of SAN DIEGO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2020-09-24. The offering totals $50.0M, of which $5.0M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2020-09-24
- Form: D
- Accession: 0001825784-20-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $50.0M
- Amount sold: $5.0M
- Remaining: $45.0M
- Minimum investment: $1
- Investors: 1
- Date of first sale: 2020-09-09
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-376272

## Issuer

- Name: Jengu Therapeutics, Inc.
- CIK: 0001825784
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 6175 NANCY RIDGE DRIVE, SAN DIEGO, CA, 92121
- Phone: 858-794-4860

## Officers, directors & promoters (5)

| Name | Role | Location |
| --- | --- | --- |
| Jeremy Caldwell | Director | Seattle, WA |
| ERIC FISCHER | Director | SAN DIEGO, CA |
| Clare Ozawa | Director | South San Francisco, CA |
| Thomas Woiwode | Director | San Francisco, CA |
| Jeremy Caldwell | Executive Officer | Seattle, WA |

## More

- [CIK 1825784 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1825784&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001825784-20-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.